Acadian Asset Management
RDHL

Acadian Asset Management’s Redhill Biopharma RDHL Stock Holding History

Acadian Asset Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-918
Closed -$93K – 1879
2023
Q1 		$93K Buy
918
+258
+39% +$48.7K ﹤0.01% 1407
2022
Q4 		$92K Buy
+660
New +$286K ﹤0.01% 1454
2022
Q3 		– Sell
-31
Closed -$27K – 1812
2022
Q2 		$27K Buy
31
+14
+82% +$19.2K ﹤0.01% 1584
2022
Q1 		$42K Buy
17
+9
+113% +$21.3K ﹤0.01% 1489
2021
Q4 		$19K Buy
+8
New +$32K ﹤0.01% 1616

Other funds holding RDHL

CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $97.7B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return